VANCOUVER, Feb. 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , is scheduled to participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.
Thomas Bailey, Chief Financial Officer of Angiotech, will be making a 40-minute presentation at the conference on Wednesday, February 8th, 2006 at 1:40 pm EST (10:40 am PST). This audio-only webcast presentation will be available through Angiotech's website at www.angiotech.com.
Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for poorly addressed disease states and dramatically improve surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. , please visit our website at www.angiotech.com
FOR ADDITIONAL INFORMATION: --------------------------- Analysts and Investors: Todd Young, Vice President Investor Relations and Communications Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6933 Media: Colleen Beauregard Waggener Edstrom Bioscience (503) 443-7863, Email: colleenb@wagged.com
Angiotech Pharmaceuticals, Inc.CONTACT: Analysts and Investors: Todd Young, Vice President InvestorRelations and Communications, Angiotech Pharmaceuticals, Inc., (604)221-7676 ext 6933; Media: Colleen Beauregard, Waggener Edstrom Bioscience,(503) 443-7863, Email: colleenb@wagged.com
